Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

There's something about drugstores that have a unique appeal to most American consumers. Easy accessibility, immediate need products and a convenient location to pick up their latest pharmaceuticals.

Walgreens Boots Alliance: Cheap Stock, but for Good Reasons

Walgreens has been simplifying and transforming its business at the same time. The company has a massive job to do, and is still full in its transition.

Walgreens: Continued Transformation

Amgen

Gilead Sciences

Intel

Kraft Heinz

The Nasdaq has been absolutely obliterated this year, down a stunning 21.2%, which puts the tech-heavy index firmly in bear market territory.

Why the 5 Highest-Yielding Nasdaq Stocks May Be the Best and Safest Value Buys Now

Walgreens is committed to selling its U.K. Boots pharmacy in 2022. Cash proceeds from the sale could pay down debt and/or be used to accelerate the U.S. store makeover effort into a higher-margin health and wellness business.

Walgreens: Selling Boots Could Revive Wall Street Interest

The S&P 500 Index (SPX) is headed towards an unseasonably bearish April.

History Says This is the Worst Dow Stock to Own in May

Abbott Labs

Intuitive Surgical

Pfizer

UnitedHealth Group

People will always need medical treatment regardless of what is going on with the economy, which makes stocks in the healthcare sector consistently reliable investments.

The 5 Best Healthcare Stocks To Own Right Now

AbbVie

Best Buy

Conagra Brands

Darden Restaurants

Fidelity National Financial

Southern Copper

Whether in a bull market, bear market, or something in-between, make these seven high-quality dividend stocks long-term portfolio holdings. The post 7 A-Rated Dividend Stocks to Buy Forever appeared first on InvestorPlace.

7 A-Rated Dividend Stocks to Buy Forever

DEERFIELD, Ill. & CHICAGO--(BUSINESS WIRE)--Village Medical at Walgreens primary care and pharmacy services help patients better manage their health, through easy access and high-quality care

Walgreens and VillageMD Expand to Massachusetts with Goal of Opening More Than 10 New Full-Service, Primary Care Practices by Early 2023

Apollo Global Management

(Reuters) -Indian conglomerate Reliance Industries Ltd and U.S. buyout firm Apollo Global Management are planning a joint bid for UK high street pharmacy chain Boots, a spokesperson for Apollo confirmed on Wednesday.

India's Reliance, Apollo Global plan joint bid for Walgreens' Boots business

Pharmacy chain Walgreens Boots Alliance and other defendants on Tuesday said they were not to blame for the opioid crisis in San Francisco, and that they acted responsibly when providing legal medications to patients in pain.

Walgreens, drugmakers blame others for San Francisco's opioid crisis

Personal Care Brand to Prioritize Sustainability and Accessibility at the Integrated Healthcare and Pharmacy Retailer NEW YORK , April 26, 2022 /PRNewswire/ -- Hey Humans, a trailblazer in eco-conscious personal care has announced greater access to high performance, clean and sustainably-packaged personal care at over 6,0000 Walgreens retail locations nationwide and on walgreens.com. The brand's thoughtfully curated product assortment, made with sustainability in mind, is 99% plastic-free cross category.

Hey Humans Announces Exciting Expansion into Walgreens

Teva Pharmaceutical

San Francisco will square off on Monday against Walgreens Boots Alliance and three other companies accused of fueling an opioid crisis in the city, the first trial to target manufacturers, distributors and pharmacies over the addictive pain medicines.

Walgreens, Teva face San Francisco trial over opioid epidemic

NextEra Energy

Not all high-quality dividend stocks are created equally.

2 Dividend Aristocrats to Buy Hand Over Fist and 1 to Avoid Like the Plague

Alphabet

This technology has the potential to deliver value to billions of people.

Walgreens & Alphabet Launch Inaugural Drone Deliveries In DFW

Dow Inc

Verizon

When April ends in a little more than a week, we will officially be a third of the way through what has been for the most part a very dismal 2022 for investors.

The 5 Highest-Yielding Dow Stocks Are Outstanding Q2 Buys Now

CVS Health

Rite Aid

They're not as great as the arguments in favor might make it seem.

Why These Pharmacy Stocks Aren't a Good Option for Retirement Savings

CrowdStrike

Here are three of the best long-term stocks to invest in with tax refunds this year The post Want to Invest Your Tax Refund? 3 Long-Term Stocks to Consider appeared first on InvestorPlace.

Want to Invest Your Tax Refund? 3 Long-Term Stocks to Consider

Walgreens CEO Roz Brewer was the highest paid female chief executive in 2021, according to a new Equilar study.

Walgreens CEO Roz Brewer was the highest paid female CEO in 2021, according to a new report

DEERFIELD, Ill.--(BUSINESS WIRE)--For the eighth year in a row, Walgreens is celebrating Red Nose Day as the exclusive retailer of the nationwide campaign to help end the cycle of child poverty and ensure a healthy future for all children. After two years of only the digital Red Nose filter being available due to the COVID-19 pandemic, customers can once again purchase the iconic Red Nose at their local Walgreens now through May 31, in addition to using the digital Red Nose filter. In partnersh

The Iconic Red Nose is Back Exclusively at Walgreens to Support Healthy Communities and Help End Child Poverty

There are many reasons why Reliance may be interested in an organization like Walgreens Boots.

Reliance, India's Largest Company, May Potentially Buy Walgreens' Drugstore Business

India's Reliance Industries may bid for Walgreens Boots Alliance's UK-based Boots business, Bloomberg News reported on Wednesday.

India's Reliance may bid for Walgreens' Boots business - Bloomberg News

Are investors overly worried about Walgreens' future?

3 Reasons to Buy Walgreens After Its Post-Earnings Dip

Canadian Imperial Bank of Commerce

These are the types of investments you can buy and forget about for a long while.

2 Ultra-Safe Dividend Stocks That Yield More Than 4%

2022 has been a tough year for long WBA investors. Shares took a dive following Q2 FY ‘22 results despite the firm beating expectations. WBA bears make some strong arguments against the company heading into FY ‘23.

The Long Walgreens Investor: Putting Bear Arguments In Context

Kroger

Target

Baby formula is in high demand, and stores including Target, Kroger, Walgreens, and CVS are limiting what consumers can purchase, the WSJ reported.

News for Walgreens Stock (WBA)